Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Orasure Tech Inc (NQ: OSUR )

4.945 -0.285 (-5.45%)
Streaming Delayed Price Updated: 2:56 PM EDT, May 17, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Orasure Tech Inc

OraSure Reports Q1 ’24 Revenue of $54.1 Million
From OraSure Technologies, Inc.
Via GlobeNewswire
Intelligent Bio Solutions Screening Technologies Poised to Disrupt The Healthcare Sector: INBS, LH, ABT, DGX
Via AB Newswire
OraSure to Announce First Quarter 2024 Financial Results and Host Earnings Call on May 8th
From OraSure Technologies, Inc.
Via GlobeNewswire
OraSure Reports Q4 ‘23 Revenue of $75.9 Million
From OraSure Technologies, Inc.
Via GlobeNewswire
OraSure to Announce Fourth Quarter 2023 Financial Results and Host Earnings Call on February 27th
From OraSure Technologies, Inc.
Via GlobeNewswire
OraSure Technologies, Inc. Secures Strategic Distribution Rights and Invests in Sapphiros, a Next-Generation Consumer Diagnostics Company
From OraSure Technologies, Inc.
Via GlobeNewswire
OraSure to Participate in Upcoming Investor Conferences
From OraSure Technologies, Inc.
Via GlobeNewswire
OraSure Reports Q3 ‘23 Revenue of $89.2 Million; Core Revenue Grows 7% Year-over-Year
From OraSure Technologies, Inc.
Via GlobeNewswire
OraSure to Announce Third Quarter 2023 Financial Results and Host Earnings Call on November 7th
From OraSure Technologies, Inc.
Via GlobeNewswire
OraSure Reports Q2 ‘23 Revenue of $85.4 Million; Core Revenue Grows 3% Year-over-Year
From OraSure Technologies, Inc.
Via GlobeNewswire
OraSure to Announce Second Quarter 2023 Financial Results and Host Earnings Call on August 3rd
From OraSure Technologies, Inc.
Via GlobeNewswire
OraSure Technologies Elects Robert McMahon to the Board of Directors
From OraSure Technologies, Inc.
Via GlobeNewswire
Study Concludes Self-Sampling Using Colli-Pee® Device for HPV Screening Is Both Cost Effective and Could Improve Patient Access
From OraSure Technologies, Inc.
Via GlobeNewswire
OraSure Reports 1Q23 Record Revenue of $155.0 Million; Announces New Collaborations as Company Increasingly Focuses on Core Growth
From OraSure Technologies, Inc.
Via GlobeNewswire
2023 First Quarter Earnings Conference Call Wednesday, May 10, 2023, 5:00 p.m. ET
From OraSure Technologies, Inc.
Via GlobeNewswire
OraSure Reports 4Q22 Record Revenue of $123.1 Million Growing 94% Year-Over-Year; Positions for Longer-Term Growth and Profitability
From OraSure Technologies, Inc.
Via GlobeNewswire
2022 Fourth Quarter Earnings Conference Call Tuesday, February 14, 2023, 5:00 p.m. ET
From OraSure Technologies, Inc.
Via GlobeNewswire
OraSure Technologies Continues its Dedication to Ending the HIV Epidemic
Company to Ring Nasdaq Closing Bell in New York City in Observation of World AIDS Day 
From OraSure Technologies, Inc.
Via GlobeNewswire
OraSure Technologies to Present at Stephens Annual Investment Conference
From OraSure Technologies, Inc.
Via GlobeNewswire
OraSure Reports 3Q22 Record Revenue of $116.5 Million Growing 116% Year-Over-Year
From OraSure Technologies, Inc.
Via GlobeNewswire
OraSure Technologies Receives General Clearance for its ORAcollect®•Dx Device for Over-the Counter (OTC) Use from the U.S. Food and Drug Administration (FDA)
From OraSure Technologies, Inc.
Via GlobeNewswire
InteliSwab® COVID-19 Rapid Test Now Available in Amazon’s Online Store
From OraSure Technologies, Inc.
Via GlobeNewswire
2022 Third Quarter Earnings Conference Call Tuesday, November 8, 2022, 5:00 p.m. ET
From OraSure Technologies, Inc.
Via GlobeNewswire
OraSure Technologies Receives $8.6 Million BARDA Contract to Develop 2nd Generation Ebola Test
From OraSure Technologies, Inc.
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.